Publication Name	World Journal of Biological Chemistry
Manuscript ID	56749
Country	Mexico

Received	2020-05-13 02:19
Peer-Review Started	2020-05-13 02:20
To Make the First Decision
Return for Revision	2020-06-15 18:37
Revised	2020-06-30 04:01
Second Decision	2020-09-10 09:51
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2020-09-10 18:08
Articles in Press	2020-09-10 18:08
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2020-09-16 02:52
Publish the Manuscript Online	2020-09-24 09:16

ISSN	1949-8454 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Biochemistry & Molecular Biology
Manuscript Type	Minireviews
Article Title	Epigenetic basis of Alzheimer disease
Manuscript Source	Invited Manuscript
All Author List	Angeles C Tecalco-Cruz, Josué O Ramírez-Jarquín, María E Alvarez-Sánchez and Jesus Zepeda-Cervantes
Funding Agency and Grant Number
Corresponding Author	Angeles C Tecalco-Cruz, PhD, Academic Research, Posgrado en Ciencias Genómicas, Universidad Autónoma de la Ciudad de México, Av. San Lorenzo no. 290. Apdo, Mexico 03100, Mexico. angeles.tecalco@uacm.edu.mx
Key Words	Epigenetics; Aging; Neurodegenerative diseases; Alzheimer diseases; ;
Core Tip	The deregulation of non-coding ribonucleic acids and epigenetic modifications have been described in Alzheimer disease (AD). These changes have been observed in different brain regions related to learning and memory, processes that are affected in AD. The epigenetic basics in the progression of AD were integrated into this review.
Publish Date	2020-09-24 09:16
Citation	Tecalco-Cruz AC, Ramírez-Jarquín JO, Alvarez-Sánchez ME, Zepeda-Cervantes J. Epigenetic basis of Alzheimer disease. World J Biol Chem 2020; 11(2): 62-75
URL	https://www.wjgnet.com/1949-8454/full/v11/i2/62.htm
DOI	https://dx.doi.org/10.4331/wjbc.v11.i2.62

Full Article (PDF)	WJBC-11-62.pdf
Full Article (Word)	WJBC-11-62.docx
Manuscript File	56749-Review.docx
Answering Reviewers	56749-Answering reviewers.pdf
Audio Core Tip	56749-Audio core tip.wma
Conflict-of-Interest Disclosure Form	56749-Conflict-of-interest statement.pdf
Copyright License Agreement	56749-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate	56749-Language certificate.pdf
Peer-review Report	56749-Peer-review(s).pdf
Scientific Misconduct Check	56749-Bing-Yan JP-1.png
Scientific Misconduct Check	56749-Scientific misconduct check.pdf
Scientific Editor Work List	56749-Scientific editor work list.pdf